The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic
Open accessAbstract
For around three decades, the fluoroquinolone (FQ) antibiotic ciprofloxacin has been used to treat a range of diseases, including chronic otorrhea, endocarditis, lower respiratory tract, gastrointestinal, skin and soft tissue, and urinary tract infections. Ciprofloxacin's main mode of action is to stop DNA replication by blocking the A subunit of DNA gyrase and having an extra impact on the substances in cell walls. Available in intravenous and oral formulations, ciprofloxacin reaches therapeutic concentrations in the majority of tissues and bodily fluids with a low possibility for side effects. Despite the outstanding qualities of this antibiotic, Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa have all shown an increase in ciprofloxacin resistance over time. The rise of infections that are resistant to ciprofloxacin shows that new pharmacological synergisms and derivatives are required. To this end, ciprofloxacin may be more effective against the biofilm community of microorganisms and multi-drug resistant isolates when combined with a variety of antibacterial agents, such as antibiotics from various classes, nanoparticles, natural products, bacteriophages, and photodynamic therapy. This review focuses on the resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing its efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilms: an emergent form of bacterial life
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.94 · Cited by 5,979
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Microbiological effects of sublethal levels of antibiotics
Andersson, D. I., & Hughes, D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3270 · Cited by 1,757
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Li, B., & Webster, T. J. (2018) · Journal of Orthopaedic Research · doi:10.1002/jor.23656 · Cited by 907
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892
Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 845
Mechanisms of antibiotic resistance in enterococci
Miller, W. R., Munita, J. M., & Arias, C. A. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.956092 · Cited by 772
Campoli-Richards, D. M., Monk, J. P., Price, A., Benfield, P., Todd, P. A., & Ward, A. (1988) · Drugs · doi:10.2165/00003495-198835040-00003 · Cited by 749
Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations
Sun, J., Deng, Z., & Yan, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.090 · Cited by 746
Mechanisms of drug resistance: quinolone resistance
Hooper, D. C., & Jacoby, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12830 · Cited by 716
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
Hooper, D. C., & Jacoby, G. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025320 · Cited by 553
Antibiotic Resistance in Campylobacter : Emergence, Transmission and Persistence
Luangtongkum, T., Jeon, B., Han, J., Plummer, P., Logue, C. M., & Zhang, Q. (2009) · Future Microbiology · doi:10.2217/17460913.4.2.189 · Cited by 535
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance
Bush, N. G., Diez-Santos, I., Abbott, L. R., & Maxwell, A. (2020) · Molecules · doi:10.3390/molecules25235662 · Cited by 413
Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
Chaudhry, W. N., Concepción-Acevedo, J., Park, T., Andleeb, S., Bull, J. J., & Levin, B. R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0168615 · Cited by 394
Ciprofloxacin derivatives and their antibacterial activities
Zhang, G.-F., Liu, X., Zhang, S., Pan, B., & Liu, M.-L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.078 · Cited by 390
Antimicrobial Resistance Mechanisms among Campylobacter
Wieczorek, K., & Osek, J. (2013) · BioMed Research International · doi:10.1155/2013/340605 · Cited by 296
Heldman, A. W., Hartert, T. V., Ray, S. C., Daoud, E. G., Kowalski, T. E., Pompili, V. J., Sisson, S. D., Tidmore, W. C., vom Eigen, K. A., Goodman, S. N., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00070-8 · Cited by 289
Clinical practice guideline: Acute otitis externa
Rosenfeld, R. M., Brown, L., Cannon, C. R., Dolor, R. J., Ganiats, T. G., Hannley, M., Kokemueller, P., Marcy, S. M., Roland, P. S., Shiffman, R. N., et al. (2006) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2006.02.014 · Cited by 270
Mogayzel, P. J., Naureckas, E. T., Robinson, K. A., Brady, C., Guill, M., Lahiri, T., Lubsch, L., Matsui, J., Oermann, C. M., Ratjen, F., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201404-166oc · Cited by 269
A Method for Generation Phage Cocktail with Great Therapeutic Potential
Gu, J., Liu, X., Li, Y., Han, W., Lei, L., Yang, Y., Zhao, H., Gao, Y., Song, J., Lu, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031698 · Cited by 268
Maruri, F., Sterling, T. R., Kaiga, A. W., Blackman, A., van der Heijden, Y. F., Mayer, C., Cambau, E., & Aubry, A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr566 · Cited by 264
Plasmid-mediated quinolone resistance: Two decades on
Rodríguez-Martínez, J. M., Machuca, J., Cano, M. E., Calvo, J., Martínez-Martínez, L., & Pascual, A. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.09.001 · Cited by 232
Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem
Rehman, A., Patrick, W. M., & Lamont, I. L. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000873 · Cited by 226
Fasugba, O., Gardner, A., Mitchell, B. G., & Mnatzaganian, G. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1282-4 · Cited by 216
Kang, C.-I., Kim, J., Park, D. W., Kim, B.-N., Ha, U.-S., Lee, S.-J., Yeo, J. K., Min, S. K., Lee, H., & Wie, S.-H. (2018) · Infection & Chemotherapy · doi:10.3947/ic.2018.50.1.67 · Cited by 216
Trends in fluoroquinolone resistance in Campylobacter
Sproston, E. L., Wimalarathna, H. M. L., & Sheppard, S. K. (2018) · Microbial Genomics · doi:10.1099/mgen.0.000198 · Cited by 192
Sabzi, M., Afshari, M. J., Babaahmadi, M., & Shafagh, N. (2020) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2019.110757 · Cited by 174
Akturk, E., Oliveira, H., Santos, S. B., Costa, S., Kuyumcu, S., Melo, L. D. R., & Azeredo, J. (2019) · Antibiotics · doi:10.3390/antibiotics8030103 · Cited by 172
Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolates
Papkou, A., Hedge, J., Kapel, N., Young, B., & MacLean, R. C. (2020) · Nature Communications · doi:10.1038/s41467-020-17735-y · Cited by 170
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent
Eliopoulos, G. M., Gardella, A., & Moellering, R. C. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.3.331 · Cited by 165
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data
Yang, Y., Niehaus, K. E., Walker, T. M., Iqbal, Z., Walker, A. S., Wilson, D. J., Peto, T. E. A., Crook, D. W., Smith, E. G., Zhu, T., et al. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx801 · Cited by 159
How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections
Taati Moghadam, M., Amirmozafari, N., Shariati, A., Hallajzadeh, M., Mirkalantari, S., Khoshbayan, A., & Masjedian Jazi, F. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s234353 · Cited by 158
Self-citationYao, H., Shen, Z., Wang, Y., Deng, F., Liu, D., Naren, G., Dai, L., Su, C., Wang, B., Wang, S., et al. (2016) · mBio · doi:10.1128/mbio.01543-16 · Cited by 154
Zhang, Y., Chang, M., Bao, F., Xing, M., Wang, E., Xu, Q., Huan, Z., Guo, F., & Chang, J. (2019) · Nanoscale · doi:10.1039/c8nr09818b · Cited by 151
Chalkley, L. J., & Koornhof, H. J. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.331 · Cited by 150
Jørgensen, K. M., Wassermann, T., Jensen, P. Ø., Hengzuang, W., Molin, S., Høiby, N., & Ciofu, O. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00493-13 · Cited by 149
Llanes, C., Köhler, T., Patry, I., Dehecq, B., van Delden, C., & Plésiat, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00101-11 · Cited by 147
Bruchmann, S., Dötsch, A., Nouri, B., Chaberny, I. F., & Häußler, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-12 · Cited by 144
In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates
Ahmad, A., Khan, A., Khan, L. A., & Manzoor, N. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.020693-0 · Cited by 133
Transferable mechanisms of quinolone resistance
Ruiz, J., Pons, M. J., & Gomes, C. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.02.011 · Cited by 132
Bacteriophages and Lysins in Biofilm Control
Łusiak-Szelachowska, M., Weber‐Dąbrowska, B., & Górski, A. (2020) · Virologica Sinica · doi:10.1007/s12250-019-00192-3 · Cited by 132
Gutiérrez, D., Briers, Y., Rodríguez‐Rubio, L., Martínez, B., Rodríguez, A., Lavigne, R., & García, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01315 · Cited by 128
Chegini, Z., Khoshbayan, A., Vesal, S., Moradabadi, A., Hashemi, A., & Shariati, A. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00433-y · Cited by 124
Self-citationMaisch, T., Hackbarth, S., Regensburger, J., Felgenträger, A., Bäumler, W., Landthaler, M., & Röder, B. (2010) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2010.07577.x · Cited by 119
Li, Y., Liu, Y., Ren, Y., Su, L., Li, A., An, Y., Rotello, V. M., Zhang, Z., Wang, Y., Liu, Y., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004942 · Cited by 118
Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Pseudomonas aeruginosa
Gurney, J., Pradier, L., Griffin, J. S., Gougat‐Barbera, C., Chan, B. K., Turner, P. E., Kaltz, O., & Hochberg, M. (2020) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaa026 · Cited by 116
Bedaquiline: Current status and future perspectives
Khoshnood, S., Goudarzi, M., Taki, E., Darbandi, A., Kouhsari, E., Heidary, M., Motahar, M., Moradi, M., & Bazyar, H. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.02.017 · Cited by 109
Self-citationEffects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli
Valério, N., Oliveira, C., Jesus, V. I. R., Branco, T. M., Pereira, C., Moreirinha, C., & Almeida, A. (2017) · Virus Research · doi:10.1016/j.virusres.2017.07.015 · Cited by 107
Aqil, F., Ahmad, I., & Owais, M. (2006) · Biotechnology Journal · doi:10.1002/biot.200600130 · Cited by 106
Ciprofloxacin concentrations in bone and muscle after oral dosing
Fong, I. W., Ledbetter, W. H., Vandenbroucke, A., Simbul, M., & Rahm, V. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.3.405 · Cited by 106
Ibraheem, D. R., Hussein, N. N., Sulaiman, G. M., Mohammed, H. A., Khan, R. A., & Rugaie, O. A. (2022) · Nanomaterials · doi:10.3390/nano12162808 · Cited by 105
Synergistic antimicrobial effect of photodynamic therapy and ciprofloxacin
Ronqui, M. R., Coletti, T. M. S. F. D. A., de Freitas, L. M., Miranda, E. T., & Fontana, C. R. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.02.036 · Cited by 102
Günday, C., Anand, S., Gencer, H. B., Munafò, S., Moroni, L., Fusco, A., Donnarumma, G., Ricci, C., Hatir, P. Ç., Günday-Türeli, N., et al. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00736-1 · Cited by 100
Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis
Rodrigues, L., Villellas, C., Bailo, R., Viveiros, M., & Aínsa, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01482-12 · Cited by 98
Role of a qnr -Like Gene in the Intrinsic Resistance of Enterococcus faecalis to Fluoroquinolones
Arsene, S., & Leclercq, R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00274-07 · Cited by 98
Activity of levofloxacin and ciprofloxacin against urinary pathogens
Drago, L. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.37 · Cited by 97
Esfahanian, M., Ghasemzadeh, M. A., & Razavian, S. M. H. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1617729 · Cited by 97
Pankuch, G. A., Lin, G., Seifert, H., & Appelbaum, P. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00689-07 · Cited by 95
Benedini, L. A., Laiuppa, J. A., Santillán, G. E., Baldini, M. D., & Messina, P. V. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111101 · Cited by 94
Engeman, E., Freyberger, H. R., Corey, B. W., Ward, A. M., He, Y., Nikolich, M. P., Filippov, A. A., Tyner, S. D., & Jacobs, A. C. (2021) · Pharmaceuticals · doi:10.3390/ph14030184 · Cited by 93
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century
Młynarczyk-Bonikowska, B., Majewska, A., Malejczyk, M., Młynarczyk, G., & Majewski, S. T. (2019) · Medical Microbiology and Immunology · doi:10.1007/s00430-019-00651-4 · Cited by 92
Cambau, E., Viveiros, M., Machado, D., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku438 · Cited by 91
An Optimized Checkerboard Method for Phage-Antibiotic Synergy Detection
Nikolić, I., Vukovic, D., Gavric, D., Cvetanovic, J., Sabo, V. A., Gostimirovic, S., Narančić, J., & Knežević, P. (2022) · Viruses · doi:10.3390/v14071542 · Cited by 78
Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment
Heidary, M., Shirani, M., Moradi, M., Goudarzi, M., Pouriran, R., Rezaeian, T., & Khoshnood, S. (2022) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2021.00021 · Cited by 76
Self-citationMutations in gyrA, gyrB, parC, and parE in quinolone‐resistant strains of Neisseria gonorrhoeae
Lindbäck, E., Rahman, M., Jalal, S., et al. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.1100909.x · Cited by 75
Wang, L., di Luca, M., Tkhilaishvili, T., Trampuz, A., & González-Moreno, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02522 · Cited by 75
Current Prospects for the Fluoroquinolones as First-Line Tuberculosis Therapy
Takiff, H. E., & Guerrero, E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00695-11 · Cited by 74
Feng, Y., Jonker, M. J., Moustakas, I., Brul, S., & ter Kuile, B. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00434-16 · Cited by 74
Wicked: The untold story of ciprofloxacin
Conley, Z. C., Bodine, T. J., Chou, A., & Zechiedrich, L. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006805 · Cited by 74
Rising fluoroquinolone resistance in Campylobacter isolated from feedlot cattle in the United States
Tang, Y., Şahin, O., Pavlovic, N., LeJeune, J., Carlson, J., Wu, Z., Dai, L., & Zhang, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-00584-z · Cited by 73
Morita, Y., Tomida, J., & Kawamura, Y. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00008 · Cited by 72
Orsu, P., & Matta, S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.322 · Cited by 72
Activity of Antimicrobial Peptides and Ciprofloxacin against Pseudomonas aeruginosa Biofilms
Yasir, M., Dutta, D., & Willcox, M. D. P. (2020) · Molecules · doi:10.3390/molecules25173843 · Cited by 70
Laponogov, I., Veselkov, D. A., Crevel, I. M.-T. C., Pan, X.-S., Fisher, L. M., & Sanderson, M. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt749 · Cited by 69
Stergiopoulou, T., Meletiadis, J., Sein, T., Papaioannidou, P., Tsiouris, I., Roilides, E., & Walsh, T. J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn473 · Cited by 65
Nakaminami, H., Noguchi, N., & Sasatsu, M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01065-09 · Cited by 64
Meningococcal Quinolone Resistance Originated from Several Commensal Neisseria Species
Chen, M., Zhang, C., Zhang, X., & Chen, M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01494-19 · Cited by 64
Prusty, K., & Swain, S. K. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.12.258 · Cited by 63
Combination Effect of Engineered Endolysin EC340 With Antibiotics
Hong, H., Kim, Y. D., Jang, J., Kim, M. S., Song, M., & Myung, H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.821936 · Cited by 63
Sun, M., Zhu, C., Long, J., Lu, C. T., Pan, X., & Wu, C. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1756985 · Cited by 61
Blaettler, L., Mertz, D., Frei, R., Elzi, L., Widmer, A. F., Battegay, M., & Flückiger, U. M. (2009) · Infection · doi:10.1007/s15010-009-8457-0 · Cited by 60
Harcourt, B. H., Anderson, R. D., Wu, H. M., Cohn, A. C., MacNeil, J. R., Taylor, T. H., Wang, X., Clark, T. A., Messonnier, N. E., & Mayer, L. W. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv117 · Cited by 60
Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila
Almahmoud, I., Kay, E., Schneider, D., & Maurin, M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp173 · Cited by 59
Lari, A. R., Ardebili, A., & Hashemi, A. (2018) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_644_16 · Cited by 58
Khare, T. R., Mahalunkar, S., Shriram, V., Gosavi, S., & Kumar, V. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111321 · Cited by 57
Haroun, M., & Al-Kayali, R. (2016) · PubMed Central · doi:10.22038/ijbms.2016.7819 · Cited by 56
Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes
Yayehrad, A. T., Wondie, G. B., & Marew, T. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s348643 · Cited by 56
In-vitroandin-vivoevaluation of ciprofloxacin liposomes for pulmonary administration
Liu, C., Shi, J. C., Dai, Q., Yin, X., Zhang, X., & Zheng, A. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.858740 · Cited by 55
Parallel evolution and local differentiation in quinolone resistance in Pseudomonas aeruginosa
Wong, A., & Kassen, R. (2011) · Microbiology · doi:10.1099/mic.0.046870-0 · Cited by 55
McShane, P. J., Weers, J. G., Tarara, T. E., Haynes, A., Durbha, P., Miller, D. P., Mundry, T., Operschall, E., & Elborn, J. S. (2018) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2018.03.005 · Cited by 54
Menon, N. D., Kumar, M. S., Babu, T. G. S., Bose, S., Vijayakumar, G., Baswe, M., Chatterjee, M., D’Silva, J., Shetty, K., Haripriyan, J., et al. (2021) · mSphere · doi:10.1128/msphere.01215-20 · Cited by 54
Shahmoradi, S., Shariati, A., Zargar, N., Yadegari, Z., Asnaashari, M., Amini, S. M., & Darban‐Sarokhalil, D. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102398 · Cited by 54
Self-citationCiprofloxacin-nitroxide hybrids with potential for biofilm control
Verderosa, A. D., de la Fuente‐Núñez, C., Mansour, S., Cao, J., Lu, T. K., Hancock, R. E. W., & Fairfull‐Smith, K. E. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.058 · Cited by 52
Tkhilaishvili, T., Wang, L., Perka, C., Trampuž, A., & Moreno, M. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00695 · Cited by 49
Zhao, J., & Dang, H. (2012) · Microbial Ecology · doi:10.1007/s00248-012-0008-z · Cited by 47
Epidemiology of qnrVC alleles and emergence out of the Vibrionaceae family
da Fonseca, É. L., & Vicente, A. C. P. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.062661-0 · Cited by 45
Heinemann, B., Wisplinghoff, H., Edmond, M. B., & Seifert, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2211-2213.2000 · Cited by 45
Potentiation of ciprofloxacin action against Gram-negative bacterial biofilms by a nitroxide
Reffuveille, F., de la Fuente‐Núñez, C., Fairfull‐Smith, K. E., & Hancock, R. E. W. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv016 · Cited by 44
In vitro drug release behavior of Ce-doped nano-bioactive glass carriers under oxidative stress
Farag, M. M., Al‐Rashidy, Z. M., & Ahmed, M. M. (2019) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-019-6220-3 · Cited by 44
Treatment of skin and soft tissue infections in the Elderly: A review
Kish, T. D., Chang, M., & Fung, H. B. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/s1543-5946(10)80002-9 · Cited by 43
Synthesis and Evaluation of Ciprofloxacin-Nitroxide Conjugates as Anti-Biofilm Agents
Verderosa, A. D., Mansour, S., de la Fuente‐Núñez, C., Hancock, R. E. W., & Fairfull‐Smith, K. E. (2016) · Molecules · doi:10.3390/molecules21070841 · Cited by 43
Flamm, R. K., Rhomberg, P. R., Huband, M. D., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00941-16 · Cited by 43
Thymine Sensitizes Gram-Negative Pathogens to Antibiotic Killing
Liu, Y., Yang, K., Jia, Y., Shi, J., Tong, Z., & Wang, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.622798 · Cited by 42
Target Gene Sequencing To Define the Susceptibility of Neisseria meningitidis to Ciprofloxacin
Hong, E., Hedberg, S. T., Abad, R., Fazio, C., Enríquez, R., Deghmane, A., Jolley, K. A., Stefanelli, P., Unemo, M., Vázquez, J. A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02184-12 · Cited by 40
Fluoroquinolone resistance in Neisseria meningitidis in Spain
Enriquez, R., Abad, R., Salcedo, C., Perez, S., & Vázquez, J. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm452 · Cited by 40
In Vitro Synergy of Biochanin A and Ciprofloxacin against Clinical Isolates of Staphylococcus aureus
Liu, G., Liang, J., Wang, X., Li, Z., Wang, W., Guo, N., Wu, X., Shen, F., Xing, M., Liu, L., et al. (2011) · Molecules · doi:10.3390/molecules16086656 · Cited by 39
Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa : In Vitro and In Vivo Studies
Hazlett, L. D., Ekanayaka, S. A., McClellan, S. A., & Francis, R. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27200 · Cited by 39
Anwar, A., Imran, M., Ramzan, M. A., Khan, F. A., Ismail, N., Hussain, A. I., Hussain, S. M., Alsanie, W. F., & Iqbal, H. M. N. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.119 · Cited by 39
Ramadan, R. A., Bedawy, A. M., Negm, E. M., Hassan, T. H., Ibrahim, D., ElSheikh, S. M., & Amer, R. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s371248 · Cited by 38
Boas, D. V., Almeida, C., Sillankorva, S., Nicolau, A., Azeredo, J., & Azevedo, N. F. (2016) · Biofouling · doi:10.1080/08927014.2015.1131821 · Cited by 37
Liao, C.-C., Yu, H., Yang, S.-C., Alalaiwe, A. S., Dai, Y.-S., Liu, F.-C., & Fang, J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00789-5 · Cited by 37
Rosenfeld, R. M., Brown, L., Cannon, C. R., Dolor, R. J., Ganiats, T. G., Hannley, M., Kokemueller, P., Marcy, S. M., Roland, P. S., Shiffman, R. N., et al. (2006) · Otolaryngology · doi:10.1016/s0194-5998(06)00266-x · Cited by 37
Tambat, R., Jangra, M., Mahey, N., Chandal, N., Kaur, M., Chaudhary, S., Verma, D. K., Thakur, K. G., Raje, M., Jachak, S. M., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02153 · Cited by 35
Plasmidic qnrA3 Enhances Escherichia coli Fitness in Absence of Antibiotic Exposure
Michon, A., Allou, N., Chau, F., Podglajen, I., Fantin, B., & Cambau, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024552 · Cited by 34
Serizawa, M., Sekizuka, T., Okutani, A., Banno, S., Sata, T., Inoue, S., & Kuroda, M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-09 · Cited by 34
Zhu, B., Fan, Y., Xu, Z., Xu, L., Du, P., Gao, Y., & Shao, Z. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.078600-0 · Cited by 34
Malekzadegan, Y., Rastegar, E., Moradi, M., Heidari, H., & Ebrahim‐Saraie, H. S. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s206966 · Cited by 33
Parquet, M. D. C., Savage, K. A., Allan, D. S., Ang, M. T. C., Chen, W., Logan, S. M., & Holbein, B. E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00855-19 · Cited by 30
Shoji, H., Shirakura, T., Fukuchi, K., et al. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2013.12.007 · Cited by 29
Klinger, J. D., & Aronoff, S. C. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.6.679 · Cited by 29
Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
Chesson, H. W., Kirkcaldy, R. D., Gift, T. L., Owusu‐Edusei, K., & Weinstock, H. (2014) · Emerging infectious diseases · doi:10.3201/eid2004.131288 · Cited by 28
Mahkam, M., Zeynabad, F. B., Alizadeh, E., Rahimi, M., Rahimi, F., & Salehi, R. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2021.055 · Cited by 28
Elucidating the Antimycobacterial Mechanism of Action of Ciprofloxacin Using Metabolomics
Knoll, K. E., Lindeque, J. Z., Adeniji, A. A., Oosthuizen, C. B., Lall, N., & Loots, D. T. (2021) · Microorganisms · doi:10.3390/microorganisms9061158 · Cited by 28
López, M., Tenorio, C., del Campo, R., et al. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.2.87 · Cited by 27
Mechanisms of fluoroquinolone monoresistance inMycobacterium tuberculosis
Lu, J. L., Liu, M., Wang, Y., Pang, Y., & Zhao, Z. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12401 · Cited by 25
Yang, W., Zhang, M., Zhou, J., et al. (2017) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2016.2223 · Cited by 24
Yoshitani, J., Kabata, T., Arakawa, H., Kato, Y., Nojima, T., Hayashi, K., Tokoro, M., Sugimoto, N., Kajino, Y., Inoue, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68184-y · Cited by 24
Raouf, M. M. E. M., Essa, S., Achy, S. E., Essawy, M. M., Rafik, S. T., & Baddour, M. (2021) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2021.01.004 · Cited by 24
Mechanisms of resistance to antimicrobial drugs in pathogenic Gram-positive cocci
Mlynarczyk, B., Mlynarczyk, A., Kmera-Muszynska, M., Majewski, S., & Mlynarczyk, G. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710792007204 · Cited by 23
Manzulli, V., Fasanella, A., Parisi, A., Serrecchia, L., Donatiello, A., Rondinone, V., Caruso, M., Zange, S., Tscherne, A., Decaro, N., et al. (2019) · Journal of Veterinary Science · doi:10.4142/jvs.2019.20.1.58 · Cited by 23
Tai, A. S., Bell, S. C., Kidd, T. J., Trembizki, E., Buckley, C., Ramsay, K. A., David, M., Wainwright, C. E., Grimwood, K., & Whiley, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144022 · Cited by 22
Liu, J., Ding, H., Zhao, M., Tu, F., He, T., Zhang, L., Jing, Y., Rui, X., & Zhang, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.901979 · Cited by 22
Heidary, M., Bahramian, A., Hashemi, A., Goudarzi, M., Omrani, V. F., Eslami, G., & Goudarzi, H. (2016) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.63.2016.011 · Cited by 18
Self-citationDoymuş, B., Kerem, G., Karataş, A. Y., Kök, F. N., & Önder, S. (2020) · Journal of Biomaterials Applications · doi:10.1177/0885328220977765 · Cited by 18
Clonal dissemination of Staphylococcus aureus isolates causing nosocomial infections, Tehran, Iran.
Goudarzi, M., Eslami, G., Rezaee, R., Heidary, M., Khoshnood, S., & Nia, R. S. S. (2019) · PubMed Central · doi:10.22038/ijbms.2018.30067.7245 · Cited by 16
Self-citationThe treatment of urinary tract infections and use of ciprofloxacin extended release
Hickerson, A., & Carson, C. C. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.5.519 · Cited by 15
El-Wafa, W. M. A., & Ibrahim, Y. M. (2020) · Current Microbiology · doi:10.1007/s00284-019-01871-w · Cited by 15
Karki, R., Lamichhane, S., Basnet, B. B., Dahal, A., Awal, B. K., & Mishra, S. K. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s309531 · Cited by 15
Choi, J.-G., Choi, J., Mun, S., Kang, O., Bharaj, P., Shin, D.-W., Chong, M.-S., & Kwon, D. (2015) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2015.06.010 · Cited by 14
Efflux Pumps in Neisseria gonorrhoeae: Contributions to Antimicrobial Resistance and Virulence
Shafer, W. M., Yu, E. W., Rouquette, C., Golparian, D., Jerse, A. E., & Unemo, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_17 · Cited by 14
Ostapska, H., Raju, D., Corsini, R., Lehoux, M., Lacdao, I., Gilbert, S., Sivarajah, P., Bamford, N. C., Baker, P., Gravelat, F. N., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00052-22 · Cited by 14
Heidary, M., Goudarzi, H., Hashemi, A., Eslami, G., Goudarzi, M., Chirani, A. S., & Amraei, S. (2016) · Archives of Pediatric Infectious Diseases · doi:10.5812/pedinfect.38343 · Cited by 13
Self-citationAfriyie, D. K., Adu, L. B., Dzradosi, M. K., Amponsah, S. K., Ohene-Manu, P., & Manu-Ofei, F. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.30.194.15457 · Cited by 13
Fujita, K., Takata, I., Yoshida, I., Takashima, H., & Sugiyama, H. (2022) · The Journal of Antibiotics · doi:10.1038/s41429-021-00498-z · Cited by 13
Laulund, A. S., Trøstrup, H., Lerche, C. J., Thomsen, K., Christophersen, L., Calum, H., Høiby, N., & Moser, C. E. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz027 · Cited by 12
Srivastava, P., & Sivashanmugam, K. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104824 · Cited by 12
Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis
Avery, L. M., Felberbaum, C. B., & Hasan, M. S. (2018) · IDCases · doi:10.1016/j.idcr.2018.01.016 · Cited by 8
Successful Oral Ciprofloxacin Therapy of Neisseria elongata Endocarditis
Herbert, D. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014545355 · Cited by 7
Khoshnood, S., Heidary, M., Hashemi, A., Shahi, F., Saki, M., Kouhsari, E., Eslami, G., & Goudarzi, H. (2020) · Infectious Disorders - Drug Targets · doi:10.2174/1871526520999200905121220 · Cited by 7
Self-citationLaulund, A. S., Schwartz, F. A., Trøstrup, H., Thomsen, K., Christophersen, L., Calum, H., Ciofu, O., Høiby, N., & Moser, C. E. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.652012 · Cited by 7
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Shariati, A., Arshadi, M., Khosrojerdi, M. A., Abedinzadeh, M., Ganjalishahi, M., Maleki, A., Heidary, M., & Khoshnood, S.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2022-12-21
- Volume
- 10
- Pages
- 1025633-1025633
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W4313465529
- Cited by
- 337
- References
- 154
- FWCI
- 17.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.